
- Volume 0 0
IBR Is Deemed Okay After Mastectomy
Reporting in the Archives of Surgery(September 2004), researchers found thatwomen who undergo mastectomy forbreast cancer also can have immediatebreast reconstruction (IBR) at the time ofsurgery without delaying chemotherapy, ifthis treatment also is needed. The researchersnoted, however, that this optionis not without risks. Specifically, the risksinclude wound complications, which coulddelay chemotherapy, possibly jeopardizingthe patient's chance for survival.
In the current study, the researchers analyzeddata from 128 women with breastcancer (62 of whom underwent IBR and 66of whom did not). The women had a total of148 mastectomies at the UC Davis MedicalCenter in Sacramento, Calif. The rate ofwound complications (eg, infection andbleeding) was 22% in the IBR group, comparedwith 8% in the comparison group.Even with the increased rate of wound complications,IBR did not impede the start ofchemotherapy. Of all the participants, only 2patients in each group started chemotherapylater than 4 to 6 weeks after surgery.That time frame is when most physiciansprefer to begin a course of treatment.
Articles in this issue
almost 21 years ago
Geriatric Pharmacologyalmost 21 years ago
Management of Bacterial Rhinosinusitisalmost 21 years ago
Early RA Treatment Proves Beneficialalmost 21 years ago
Topical Creams Work Temporarilyalmost 21 years ago
Mental Anguish Is Common with Arthritisalmost 21 years ago
Overview of Astrocytomas?The Pharmacist's Perspectivealmost 21 years ago
Scanner Detects Hand Arthritisalmost 21 years ago
OA: All in the Familyalmost 21 years ago
Sheriff Sues Board for Searching His Rx Records Without a Warrantalmost 21 years ago
Restricting the Sale of Cold MedicationsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.